Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117876612 | 11787661 | 2 | F | 20151031 | 20160704 | 20151130 | 20160714 | EXP | GB-MHRA-EYC 00130818 | GB-TEVA-610586ACC | TEVA | 49.00 | YR | M | Y | 80.28000 | KG | 20160714 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117876612 | 11787661 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Oral | Y | U | NOT KNOWN, RETURNED THEM TO CHEMIST | 74129 | 500 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117876612 | 11787661 | HO |
| 117876612 | 11787661 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117876612 | 11787661 | Chest pain | |
| 117876612 | 11787661 | Dyspnoea | |
| 117876612 | 11787661 | Feeling abnormal | |
| 117876612 | 11787661 | Hyperhidrosis | |
| 117876612 | 11787661 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117876612 | 11787661 | 1 | 20151026 | 20151102 | 0 |